Machine Learning Tool for New Selective Serotonin and Serotonin–Norepinephrine Reuptake Inhibitors

Machine Learning Tool for New Selective Serotonin and Serotonin–Norepinephrine Reuptake Inhibitors

Depression, a serious mood disorder, affects about 5% of the population. Currently, there are two groups of antidepressants that are the first-line treatment for depressive disorder: selective serotonin reuptake inhibitors and serotonin–norepinephrine reuptake inhibitors. The aim of the study was to...

Full description

Bibliographic Details
Main Authors: Natalia Łapińska, Jakub Szlęk, Adam Pacławski, Aleksander Mendyk
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Molecules
Subjects:
depression
QSAR model
SERT
NET
artificial Intelligence
SerotoninAI
Online Access:https://www.mdpi.com/1420-3049/30/3/637

Internet

https://www.mdpi.com/1420-3049/30/3/637

Similar Items